Texas Instruments Incorporated (TXN)

Revenue growth exceeding 1.5x Technology median of 2.70%. Joel Greenblatt would verify if operating margins keep pace with this top-line surge.

Gross profit growth exceeding 1.5x Technology median of 1.17%. Joel Greenblatt would check if cost advantages or brand equity drive this surge.

EBIT growth of 18.97% while Technology median is zero. Walter Schloss would see a marginal edge that could be expanded upon.

Operating income growth of 18.97% while Technology median is zero. Walter Schloss might see a modest advantage that can expand.

Net income growth of 18.22% while Technology median is zero. Walter Schloss might see potential if moderate gains can keep rising.

EPS growth of 16.67% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.

Diluted EPS growth of 20.00% while Technology median is zero. Walter Schloss might see a slight edge that could improve over time.

Dividend growth of 98.97% while Technology median is flat. Walter Schloss might appreciate at least a modest improvement.

OCF growth of 62.09% while Technology is zero. Walter Schloss might see a modest positive difference, which can compound over time.

FCF growth of 93.07% while Technology median is zero. Walter Schloss might see a slight edge that could compound over time.

10Y revenue/share CAGR exceeding 1.5x Technology median of 19.78%. Joel Greenblatt would verify if a unique moat or brand fosters outperformance over a decade.

5Y revenue/share growth exceeding 1.5x Technology median of 28.84%. Joel Greenblatt would see if the company’s moat drives rapid mid-term expansion.

3Y revenue/share growth exceeding 1.5x Technology median of 17.23%. Joel Greenblatt might see a short-term competitive advantage at play.

OCF/share CAGR of 58.50% while Technology median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.

OCF/share CAGR of 206.80% while Technology median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.

3Y OCF/share growth of 117.86% while Technology median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.

Net income/share CAGR exceeding 1.5x Technology median of 22.91% over a decade. Joel Greenblatt might see a standout compounder of earnings.

5Y net income/share CAGR > 1.5x Technology median of 65.07%. Joel Greenblatt might see superior mid-term capital allocation or product strength.

3Y net income/share CAGR > 1.5x Technology median of 21.74%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.

Equity/share CAGR of 174.56% while Technology median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.

5Y equity/share CAGR of 33.59% while Technology median is zero. Walter Schloss sees a slight positive that might compound if management executes well.

3Y equity/share CAGR of 13.44% while Technology median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.

Dividend/share CAGR of 271.51% while Technology is zero. Walter Schloss sees a minor improvement that could compound if the firm maintains consistent raises.

5Y dividend/share CAGR of 247.95% while Technology is zero. Walter Schloss sees at least some improvement that could compound over time.

3Y dividend/share CAGR of 281.54% while Technology is zero. Walter Schloss sees a slight advantage if the firm is at least inching up payouts.

Asset growth of 1.96% while Technology median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.

BV/share growth of 2.22% while Technology is zero. Walter Schloss sees a slight lead that can expand if sustained over time.

R&D dropping while Technology median is rising. Seth Klarman wonders if we risk ceding future innovation or if peers overspend.